Medicine Information

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers


Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently. Studies showed that they increase the likelihood of strokes and heart attacks among patients that take them for prolonged periods of time. This represents an unusual move for a pharmaceutical company, as they tend to spend a large portion of their annual advertising budget on direct-to-consumer advertising.

It is possible that Bristol Myers recognizes that consumers are becoming concerned about new drugs being approved by the FDA and advertised heavily, only to find out later that the drugs have previously unknown and possibly dangerous side effects. Consumers have learned that advertising a drug as "new and improved" doesn't necessarily mean that it is new, or improved, or even safe. In short, customers are suspicious of pharmaceutical advertising, and the drug companies are to be commended for taking notice of that fact.

Since 1997, drug companies have been allowed by U.S. law to advertise directly to consumers. This has led to an astonishing number of ads on television and radio, as consumers see ads showing one happy person after another. The ads suggest that the happiness shown is a result of the use of the product, and a voiceover quickly mumbles through the known, and sometimes lengthy, list of side effects. Patients are encouraged to speak with their doctor, and they have been doing so in record numbers. The problem, as Bristol Myers know realizes, is that consumers are well aware that the withdrawn Bextra and Vioxx were advertised as being safe. This has naturally led to a general suspicion of all advertised drugs, and Bristol Myers correctly sees that they could be the victims of a drug-company backlash, even if they didn't manufacture any of the withdrawn products.

This will probably save Bristol Myers a lot of money in the short term, as their advertising would have largely gone to waste. The Food and Drug Administration is taking steps to make sure that the drugs that reach the U.S. market are safe, and in time, the public will again become more trusting of pharmaceutical advertising. In the meantime, TV viewers will be spared from having to watch the sometimes-cryptic drug ads, which often prompt questions of "What does this drug do?"

〤opyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


New York Post

Venezuelans with transplants live in fear as medicine runs out
New York Post
After years leading normal lives, they now live in fear as Venezuela's economic collapse under President Nicolas Maduro has left the once-prosperous OPEC nation unable to purchase sufficient foreign medicine or produce enough of its own. Some 31 ...
PETRO's backing (from Whitepaper) - El PetroEl Petro
Venezuela: 82.4M Units of Petro Cryptocurrency AvailableteleSUR English

all 177 news articles »


#MeToo in medicine: Women, harassed in hospitals and operating ...
NBCNews.com
In a months-long investigation, NBC News spoke with nearly a dozen women and experts who described widespread misconduct in hospitals and health care.

and more »


OncLive

Gastrointestinal Cancers Entering Age of Precision Medicine
OncLive
He: We had 4 excellent faculty who talked about the updates to pancreatic and hepatobiliary cancer treatment, treatment of neuroendocrine tumors (NETs) of the GI tract, and precision medicine. Molecular profiling has been identified as a very important ...



The Courier-Journal

University of Louisville takes its medicine and starts healing process | Tim Sullivan
The Courier-Journal
There's never a wrong time to do the right thing. There's rarely a point where a public institution is better served by technicalities than truth. The University of Louisville has paid a high price for coming clean with its dirty laundry, with self ...

and more »


MyNorthwest.com

Ayurveda: a 5000 year old tradition of eating where food is medicine
MyNorthwest.com
Singer songwriter Nicki Bluhm is the latest guest on my podcast, Your Last Meal. For her last meal she wants a classic steakhouse dinner, complete with scalloped potatoes and creamed spinach. But in her daily life, she follows an Ayurvedic diet; a 5 ...



讙诇讜讘住

Globes English - Vaica reminds patients to take medicine - 讙诇讜讘住
讙诇讜讘住
The Israeli company adapts its reminders to the patient's age and the type of medicine.

and more »


VentureBeat

4 ways AI could help shape the future of medicine
VentureBeat
At times, progress occurs so quickly that it's difficult to separate science fiction from real life. Just five decades ago, computers were massive, unwieldy machines running on punch cards and primitive circuits. Today, a single smartphone has more ...



PR Newswire (press release)

Personalized Lifestyle Medicine Institute to Host 2018 Thought Leaders Consortium in Tucson
PR Newswire (press release)
SEATTLE, Feb. 20, 2018 /PRNewswire/ -- The Personalized Lifestyle Medicine Institute (PLMI) will host the Sixth Annual Thought Leaders Consortium Oct. 12-13, 2018 at the Westin La Paloma Resort and Spa in Tucson, Arizona. The title of the 2018 ...

and more »


Equities Focus

Loxo Oncology Will Fulfill The Promise Of Precision Medicine
Seeking Alpha
Based in Stamford, Connecticut, Loxo Oncology is dedicated to developing precision medicines against genetically defined cancers. Its highly selective drugs in the pipeline will shift the paradigm of cancer treatment from the traditional "one-size-fits ...
Financial Newsletter - ZacksZacks
Loxo Oncology, Inc. - LOXO - Stock Price Today - ZacksZacks

all 39 news articles »


Huntington Herald Dispatch

UCD School of Medicine scores high in NIH research funding
Davis Enterprise
For the first time, UC Davis School of Medicine has ranked in the top 20 percent of institutions in the country for research funding from the National Institutes of Health. 鈥淭he proportion of NIH funding is an important measure of research excellence ...
National Institutes of Health guests visit School of MedicineHNN Huntingtonnews.net

all 3 news articles »

Google News

home | site map | Dr. Thad Thomas
© 2006